Effectiveness of remdesivir in hospitalized nonsevere patients with COVID-19 in Japan: A large observational study using the COVID-19 Registry Japan

OBJECTIVES: To evaluate the effectiveness of remdesivir in the early stage of nonsevere COVID-19. Although several randomized controlled trials have compared the effectiveness of remdesivir with that of a placebo, there is limited evidence regarding its effect in the early stage of nonsevere COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuzuki, Shinya, Hayakawa, Kayoko, Uemura, Yukari, Shinozaki, Tomohiro, Matsunaga, Nobuaki, Terada, Mari, Suzuki, Setsuko, Asai, Yusuke, Kitajima, Koji, Saito, Sho, Yamada, Gen, Shibata, Taro, Kondo, Masashi, Izumi, Kazuo, Hojo, Masayuki, Mizoue, Tetsuya, Yokota, Kazuhisa, Nakamura-Uchiyama, Fukumi, Saito, Fumitake, Sugiura, Wataru, Ohmagari, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857764/
https://www.ncbi.nlm.nih.gov/pubmed/35192953
http://dx.doi.org/10.1016/j.ijid.2022.02.039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857764/
https://www.ncbi.nlm.nih.gov/pubmed/35192953
http://dx.doi.org/10.1016/j.ijid.2022.02.039

Ejemplares similares